Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
- Authors
-
-
Leslie C. Costello
School of Dentistry Department of Oncology and Diagnostic Sciences and the Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
-
- Keywords:
- Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.
- Abstract
-
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
- Downloads
-
Download data is not yet available.
- References
-
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
- Downloads
- Published
- 15-08-2018
- Issue
- Vol. 7 No. 3 (2018)
- Section
- Articles
How to Cite
Similar Articles
- Nikhil Vasdev, Patricia McClurey, Debra Gray, Aftab Bhatti, David Chadwick, An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients with Advanced Metastatic Prostate Cancer - , Journal of Cancer Research Updates: Vol. 2 No. 1 (2013)
- Jun Jiang, Wei Hong Wei, Tao Xu, Clinical Analysis of Apatinib in the Treatment of Patients with Residual Tumor after Radical Chemoradiotherapy for Locally Advanced Cervical Cancer , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Shaimaa A. Soliman, Laila A. Rashed, Mahmoud M. Said, Amina M. Medhat, Assessment of Gene Expression Level of ATP Binding Cassette G Member 2 (ABCG2) Transporter in Newly Diagnosed Breast Cancer Patients Receiving Adjuvant Chemotherapy , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Raafat S. Alameddine, Nagi S. El Saghir, Elias Elias, Ahmad Saleh, Fady B. Geara, Sally Temraz, Ali Shamseddine, Effects of Nodal Status and Extent of Surgery on Survival in Triple Negative Breast Cancer , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Luigi Cristiano, The Biological Role of Cervical Cancer Suppressor 3 (CCS-3): Literature Review , Journal of Cancer Research Updates: Vol. 10 (2021)
- Juan Manuel Seoane-Romero, Pablo Ignacio Varela-Centelles, Pedro Diz-Dios, Isabel Ramos-Barbosa, Javier Fernández Feijoo, Juan Seoane, Does Tumour Biological Behaviour Influence Prognosis More than Diagnostic Delay in Oral Cancer? , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Pankaj Deka, Amal Chandra Kataki, Debabrata Barmon, Bibhuti Bhushan Borthakur, Sushruta Shrivastava, Peritoneal Carcinomatosis with Displaced IUCD , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Christopher Krauss, Chelsey Aurelius, Kayla Johnston, Victoria Bartlette, Sherrita Gavin, Jazmine Cuffee, Satyendra Banerjee, Sarah Wiseniewsky, Santosh Mandal, Hirendra Nath Banerjee, An Investigation to Study the Role of Novel Rhenium Compounds on Endometrial Uterine Cancer Cell Lines , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Mian Chen, Inorganic Nanoplatforms for Simultaneous Cancer Imaging and Therapy: Status and Challenges , Journal of Cancer Research Updates: Vol. 6 No. 1 (2017)
- Ladislav Novotny, Samuel B. Kombian , Vanadium: Possible Use in Cancer Chemoprevention and Therapy , Journal of Cancer Research Updates: Vol. 3 No. 2 (2014)
You may also start an advanced similarity search for this article.